🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 01626L105
- Market Cap
- Mid Cap
- IPO
- 10/16/2020 · $15.00/share
Business: Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. ligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
Company Contact
- CEO
- Lawrence M. Blatt
- CFO
- Lesley Ann Calhoun
- Headquarters
- One Corporate Dr., 2nd Floor, South San Francisco, CA 94080
- Phone
- 800-466-6059
- Investor Relations
- Jordyn Tarazi · 650-910-0427 · jtarazi@aligos.com